Hannah is originally from New Jersey and recently joined the Pharmaceutical Sciences PhD Program at University of Colorado Anschutz Medical Campus (2019). Her thesis work in Dr. Jed Lampe’s lab involves modeling the structure-inhibitory relationship (QSIR) between drug substrates and CYP3A7, the main metabolizing enzyme expressed in neonates, and predicting drug-drug interactions by in vitro screening methods. Before joining UC AMC and beginning her thesis work, Hannah received her Bachelor of Sciences in Chemical Engineering from Rowan University with a concentration in Biological Engineering (2015-2019). During her undergraduate studies, she was involved in many research projects not directly related to her degree. She interned at Dupont for 6 months, during which her project consisted of enhancing the glucose utilization of one of their bacterial plasmids using CRISPR-Cas9 technology. She was also awarded NASA funding to work with Dr. Nathaniel Nucci, a biophysics professor at Rowan University. Hannah is currently a member of the American Association of Pharmaceutical Sciences (AAPS), the American Society for Pharmacology and Experimental Therapeutics (ASPET), and the Biophysical Society (BPS). She is also involved in mentoring programs, such as Young Hands in Science on the CU AMC campus, and is also the Student Representative of the Pharmaceutical Sciences Program.